JCB logo
MBoC5 from Garland Science
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published 16 January 2006. doi:10.1083/jcb1722iti4
The Rockefeller University Press, 0021-9525 $8.00
JCB, Volume 172, Number 2, 165-165
This Article
Right arrow PDF (Full Text)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tuma, R. S.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Tuma, R. S.
Related Collections
Right arrowRelated Article
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

In This Issue

NO induces myoblast fusion


Figure 1
Muscle cells (left) fuse when treated with cGMP (right) or NO.

Nitric oxide (NO) functions at numerous points in muscle development and function. On page 233, Pisconti et al. add one more item to that list: NO stimulates myoblast fusion via cGMP signaling and follistatin. Increasing NO in vivo stimulates muscle fiber formation, which suggests a potential therapeutic approach for muscular dystrophy.

Addition of an NO-releasing compound to cultures of embryonic myoblasts or satellite cells, which function as stem cells in adult muscles, stimulated cell fusion. Conversely, addition of an inhibitor of nitric oxide synthase blocked fusion.

When the team added NO to cells but blocked production of cGMP, a known mediator of NO signaling, fusion was inhibited in a cGMP-reversible manner. Significantly, prolonged exposure of the myoblasts to a nonhydrolysable analogue of cGMP induced the formation of abnormally large muscle fibers in culture. A similar effect was not observed with extended exposure to an NO donor.

RT-PCR analysis of NO-treated myoblasts showed that follistatin, a protein known to trigger myoblast fusion, was up-regulated relative to untreated cells. Another fusion-promoting protein, insulin growth factor-1 (IGF-1) was not increased.

The results suggest that NO donors may be valuable as therapies for muscular dystrophy. Preliminary testing in animal models supports that idea.Formula



Rabiya S. Tuma

rabiya@nasw.org


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Article

Follistatin induction by nitric oxide through cyclic GMP: a tightly regulated signaling pathway that controls myoblast fusion
Addolorata Pisconti, Silvia Brunelli, Monica Di Padova, Clara De Palma, Daniela Deponti, Silvia Baesso, Vittorio Sartorelli, Giulio Cossu, and Emilio Clementi
J. Cell Biol. 2006 172: 233-244. [Abstract] [Full Text] [PDF]




This Article
Right arrow PDF (Full Text)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tuma, R. S.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Tuma, R. S.
Related Collections
Right arrowRelated Article
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents